RPPA is a revolutionizing antibody-based proteomic technology that can quantitatively measure hundreds of post-translationally modified signaling molecules. Owing to its high throughput, sensitivity, and cost effectiveness, the application of RPPA technology is now rapidly expanding from basic research to clinical medicine.

More information